More than 10,000 Suboxone lawsuits have been filed against Indivior, highlighting how the drug maker failed to adequately warn that Suboxone may cause tooth decay.
Suboxone manufacturer attempts to argue that failure to warn and design defect claims over tooth decay risks should be preempted by federal law.
Kratom side effects have been linked to dozens of deaths, according to the FDA, which warns consumers to throw the dietary supplement away.
Lawyers have been ordered to submit proposals for exchanging information that will guide the selection of representative Suboxone dental claims for bellwether discovery and test trials.
Doctors were less likely to prescribe opioid addiction medications to Blacks, Latinos and women, CDC researchers discovered.
A tolling agreement for Suboxone tooth decay lawsuits will provide additional time for potential claims to be investigated before they are placed on the MDL docket, where more than 10,000 individual lawsuits may soon have to be filed
As a result of the order, lawsuits over Suboxone tooth decay will move forward with a standard discovery process, preparing a small group of representative cases for early test trials in the federal MDL.
Suboxone lawsuit bundled complaint filed just before two-year anniversary of FDA label warning linking the film strips to tooth decay risks.
Lawyers will take certain actions that benefit all plaintiffs pursuing Suboxone dental decay lawsuits in the MDL, which is soon expected to include thousands of claims brought by individuals nationwide.
Separating the litigation to prioritize discovery into the link between Suboxone and tooth decay risks will unnecessarily delay claims for years, plaintiffs attorneys argue
